{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.3136","meta":{"versionId":"5","lastUpdated":"2020-08-18T10:21:27.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>COVID19 ICD10CM Value Set for Coagulopathies</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://hl7.org/fhir/sid/icd-10-cm</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>D65</td>\n              <td>Disseminated intravascular coagulation [defibrination syndrome]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D65-D69</td>\n              <td>Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D66</td>\n              <td>Hereditary factor VIII deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D67</td>\n              <td>Hereditary factor IX deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68</td>\n              <td>Other coagulation defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.0</td>\n              <td>Von Willebrand's disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.1</td>\n              <td>Hereditary factor XI deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.2</td>\n              <td>Hereditary deficiency of other clotting factors</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.3</td>\n              <td>Hemorrhagic disorder due to circulating anticoagulants</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.31</td>\n              <td>Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.311</td>\n              <td>Acquired hemophilia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.312</td>\n              <td>Antiphospholipid antibody with hemorrhagic disorder</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.318</td>\n              <td>Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.32</td>\n              <td>Hemorrhagic disorder due to extrinsic circulating anticoagulants</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.4</td>\n              <td>Acquired coagulation factor deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.5</td>\n              <td>Primary thrombophilia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.51</td>\n              <td>Activated protein C resistance</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.52</td>\n              <td>Prothrombin gene mutation</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.59</td>\n              <td>Other primary thrombophilia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.6</td>\n              <td>Other thrombophilia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.61</td>\n              <td>Antiphospholipid syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.62</td>\n              <td>Lupus anticoagulant syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.69</td>\n              <td>Other thrombophilia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.8</td>\n              <td>Other specified coagulation defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D68.9</td>\n              <td>Coagulation defect, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69</td>\n              <td>Purpura and other hemorrhagic conditions</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.0</td>\n              <td>Allergic purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.1</td>\n              <td>Qualitative platelet defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.2</td>\n              <td>Other nonthrombocytopenic purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.3</td>\n              <td>Immune thrombocytopenic purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.4</td>\n              <td>Other primary thrombocytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.41</td>\n              <td>Evans syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.42</td>\n              <td>Congenital and hereditary thrombocytopenia purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.49</td>\n              <td>Other primary thrombocytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.5</td>\n              <td>Secondary thrombocytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.51</td>\n              <td>Posttransfusion purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.59</td>\n              <td>Other secondary thrombocytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.6</td>\n              <td>Thrombocytopenia, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.8</td>\n              <td>Other specified hemorrhagic conditions</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D69.9</td>\n              <td>Hemorrhagic condition, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>Z14.02</td>\n              <td>Symptomatic hemophilia A carrier</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.3136","version":"20200714","name":"COVID19 ICD10CM Value Set for Coagulopathies","status":"active","date":"2020-07-14T01:01:04-04:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"D65","display":"Disseminated intravascular coagulation [defibrination syndrome]"},{"code":"D65-D69","display":"Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)"},{"code":"D66","display":"Hereditary factor VIII deficiency"},{"code":"D67","display":"Hereditary factor IX deficiency"},{"code":"D68","display":"Other coagulation defects"},{"code":"D68.0","display":"Von Willebrand's disease"},{"code":"D68.1","display":"Hereditary factor XI deficiency"},{"code":"D68.2","display":"Hereditary deficiency of other clotting factors"},{"code":"D68.3","display":"Hemorrhagic disorder due to circulating anticoagulants"},{"code":"D68.31","display":"Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors"},{"code":"D68.311","display":"Acquired hemophilia"},{"code":"D68.312","display":"Antiphospholipid antibody with hemorrhagic disorder"},{"code":"D68.318","display":"Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors"},{"code":"D68.32","display":"Hemorrhagic disorder due to extrinsic circulating anticoagulants"},{"code":"D68.4","display":"Acquired coagulation factor deficiency"},{"code":"D68.5","display":"Primary thrombophilia"},{"code":"D68.51","display":"Activated protein C resistance"},{"code":"D68.52","display":"Prothrombin gene mutation"},{"code":"D68.59","display":"Other primary thrombophilia"},{"code":"D68.6","display":"Other thrombophilia"},{"code":"D68.61","display":"Antiphospholipid syndrome"},{"code":"D68.62","display":"Lupus anticoagulant syndrome"},{"code":"D68.69","display":"Other thrombophilia"},{"code":"D68.8","display":"Other specified coagulation defects"},{"code":"D68.9","display":"Coagulation defect, unspecified"},{"code":"D69","display":"Purpura and other hemorrhagic conditions"},{"code":"D69.0","display":"Allergic purpura"},{"code":"D69.1","display":"Qualitative platelet defects"},{"code":"D69.2","display":"Other nonthrombocytopenic purpura"},{"code":"D69.3","display":"Immune thrombocytopenic purpura"},{"code":"D69.4","display":"Other primary thrombocytopenia"},{"code":"D69.41","display":"Evans syndrome"},{"code":"D69.42","display":"Congenital and hereditary thrombocytopenia purpura"},{"code":"D69.49","display":"Other primary thrombocytopenia"},{"code":"D69.5","display":"Secondary thrombocytopenia"},{"code":"D69.51","display":"Posttransfusion purpura"},{"code":"D69.59","display":"Other secondary thrombocytopenia"},{"code":"D69.6","display":"Thrombocytopenia, unspecified"},{"code":"D69.8","display":"Other specified hemorrhagic conditions"},{"code":"D69.9","display":"Hemorrhagic condition, unspecified"},{"code":"Z14.02","display":"Symptomatic hemophilia A carrier"}]}]}}